Dr.Acharya Laboratories Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 02-07-2024
- Paid Up Capital ₹ 2.50 Cr
as on 02-07-2024
- Company Age 19 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 40.32 Cr
as on 02-07-2024
- Satisfied Charges ₹ 12.94 Cr
as on 02-07-2024
- Revenue 61.33%
(FY 2023)
- Profit 193.63%
(FY 2023)
- Ebitda 97.21%
(FY 2023)
- Net Worth 50.11%
(FY 2023)
- Total Assets 36.86%
(FY 2023)
About Dr.Acharya Laboratories
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 2.50 Cr.
The company currently has active open charges totaling ₹40.32 Cr. The company has closed loans amounting to ₹12.94 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shripati Acharya, Venkatraman Bhagwat, Anand Acharya, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24200MH2005PTC153343
- Company No.
153343
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 May 2005
- Date of AGM
27 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Dr.Acharya Laboratories?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shripati Acharya  | Director | 17-May-2005 | Current |
| Venkatraman Bhagwat | Director | 17-May-2005 | Current |
| Anand Acharya | Director | 17-May-2005 | Current |
| Usha Acharya | Director | 17-May-2005 | Current |
| Shrikant Acharya | Director | 17-May-2005 | Current |
Financial Performance of Dr.Acharya Laboratories.
Dr.Acharya Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 61.33% increase. The company also saw a substantial improvement in profitability, with a 193.63% increase in profit. The company's net worth Soared by an impressive increase of 50.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr.Acharya Laboratories?
In 2023, Dr.Acharya Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shirdi Chemicals Private LimitedActive 34 years 2 monthsShripati Acharya, Venkatraman Bhagwat and 3 more are mutual person
Asvik Pharma And Chemicals Private LimitedActive 28 years 1 monthShripati Acharya, Venkatraman Bhagwat and 3 more are mutual person
Acharya Research Centre Private LimitedActive 37 years 4 daysShripati Acharya, Anand Acharya and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Saraswat Co-Operative Bank Ltd. Creation Date: 25 Feb 2015 | ₹4.00 Cr | Open |
The Saraswat Co-Operative Bank Ltd. Creation Date: 01 Nov 2014 | ₹4.00 Cr | Open |
The Saraswat Co-Operative Bank Ltd. Creation Date: 10 Jun 2013 | ₹4.00 Cr | Open |
How Many Employees Work at Dr.Acharya Laboratories?
Dr.Acharya Laboratories has a workforce of 74 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr.Acharya Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr.Acharya Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
